Rhog Gam - ati drug cards for various medications PDF

Preview

Summary

ati drug cards for various medications...

Description

ACTIVE LEARNING TEMPLATE:

Medication

Nnatuanya STUDENT NAME Chidubem _____________________________________ Rhogram MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ immune glubulins CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION

Expected Pharmacological Action Sterile nonpyrogenic gamma globulin solution containing immunoglobulins (IgG) of at least 90% IgG, which provides passive immunity by suppressing active antibody response and formation of anti-Rho(D) (isoimmunization) in Rh-negative [Rho(D)-negative] individuals previously exposed to Rh-positive [Rho(D)-positive, Du-positive] blood.

Therapeutic Use Effective for exposure in Rh-negative women when Rh-positive fetal RBCs enter maternal circulation during third stage of labor, fetal-maternal hemorrhage (as early as second trimester), amniocentesis, or other trauma during pregnancy, termination of pregnancy, and following transfusion with Rh-positive RBC, whole blood, or components (platelets, WBC) prepared from Rh-positive blood.

Complications Injection site irritation, slight fever, myalgia, lethargy.

Medication Administration 120 mcg, 300 mcg, 1000 mcg vials

Contraindications/Precautions Rho(D)-positive patient; person previously immunized against Rho(D) factor, hypersensitivity for thimerosal (in commercial preparations), severe immune globulin hypersensitivity, bleeding disorders; pregnancy (category C), neonates, pediatric clients.

Interactions May interfere with immune response to LIVE VIRUS VACCINE; should delay use of LIVE VIRUS VACCINES for 3 mo after administration of Rho(D) immune globulin.

Nursing Interventions Obtain history of systemic allergic reactions to human immune globulin preparations prior to drug administration. Send sample of newborn's cord blood to laboratory for cross-match and typing immediately after delivery and before administration of Rho(D) immune globulin. Confirm that mother is Rho(D) and Du-negative. Infant must be Rh-positive.

Client Education Evaluation of Medication Effectiveness Use the deltoid muscle. Give in divided doses at different sites, all at once or at intervals, as long as the entire dose is given within 72 h after delivery or termination of pregnancy.

ACTIVE LEARNING TEMPLATES

Be aware that administration of Rho(D) immune globulin (antibody) prevents hemolytic disease of the newborn in a subsequent pregnancy....